RNA Networks in Disease
As my postdoc comes to an end, I plan to study various modes of RNA regulation so that we can use RNA measurements to understand dysregulation in disease.
Given the vast amount of information encoded in RNA it is important to understand how changes in RNA regulation such as alternative splicing, non-coding RNA interactions, alternative poly-adenylation and of course transcription can have broader effects on gene expression.
My postdoctoral research uncovered dramatic regulation of transcription by microRNAs, suggesting that post-transcriptional and transcriptional regulation of RNA are intrinsically linked. Going forward, I plan to determine how other modes of RNA regulation interact and use this knowledge to build better computational models of RNA networks in disease.
To what extent do microRNAs (miRNAs) affect gene expression?
miRNAs are small non-coding RNAs that have been shown to drive developmental transitions and diseases such as cancer but cause only modest repression of their direct targets. I hypothesized that miRNAs regulate transcription factors to affect global gene expression changes, and tested this hypothesis using numerous high-throughput datasets collected from cells with and without Dicer, an enzyme required for miRNA expression as shown below.
This graphical approach uncovered a large transcriptional network regulated by microRNAs, and can be used to study various other questions surrounding RNA regulation:
- How do miRNA regulate gene expression through the protein-protein interaction network?
- How much does feedback between miRNAs and transcription factors alter gene expression?
- How can miRNAs impact alternative splicing?
Building better models of RNA regulation
RNA levels can be altered by transcriptional and post-transcriptional regulation, as shown below.
Given the substantial impact of miRNA regulation on mRNA via transcription, it is necessary individually study all types of RNA regulation shown above to better understand identify any links and use this knowledge to develop better network models. Specifically I want to ask:
- How does alternative splicing effect transcriptional regulation?
- How do miRNAs impact alternative splicing?
- How does alternative poly-adenylation impact the other modes of regulation?
- To what extent does non-coding RNA play a role in gene expression?
For example, we can use better models of RNA to ask the following questions:
- Using miRNA and mRNA levels across patient cohorts in The Cancer Genome Atlas (TCGA), how can we identify putative drug targets of interest?
- Using miRNA and mRNA levels together with epigenetic data from the NIH Roadmap Epigenomics Project what proteins are most significant in distinguishing tissues?
- Using single-cell sequencing measurements, how can we identify specific proteins that give rise to differences in mRNA levels?